These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529 [TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
6. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165 [TBL] [Abstract][Full Text] [Related]
7. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. Martinez-Hernandez E; Sepulveda M; Rostásy K; Höftberger R; Graus F; Harvey RJ; Saiz A; Dalmau J JAMA Neurol; 2015 Feb; 72(2):187-93. PubMed ID: 25506781 [TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
10. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263 [TBL] [Abstract][Full Text] [Related]
11. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis. Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694 [TBL] [Abstract][Full Text] [Related]
12. Clinical and MRI phenotype of children with MOG antibodies. Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801 [TBL] [Abstract][Full Text] [Related]
16. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China. Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. Tantsis EM; Prelog K; Alper G; Benson L; Gorman M; Lim M; Mohammad SS; Ramanathan S; Brilot F; Dale RC; Dev Med Child Neurol; 2019 Sep; 61(9):1108-1116. PubMed ID: 30537075 [TBL] [Abstract][Full Text] [Related]
20. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]